Impact Factor
3.83
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.49
1,210 total citations
h5-index
36
h5 depth signal
Cited share
79.8%
225 of 282
Total citations
1,210
Citation footprint
Metric signal
3.98
External metric anchor
Self-citation
6.0%
73 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
516
Canada
110
United Kingdom
105
China
101
Australia
84
Citing Fields of Research
Neurodevelopmental Disorders
1,217
Psychiatry
315
Psychiatry & Psychology
309
Neurosciences
81
Chronobiology
41
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,683
Articles tracked across the journal lifetime
Indexed publication set
282
225 cited publications
Last 12 months
119
9.9 publications/month
Open access share
37.8%
45 OA publications in the last year
Leading citing country
United States
516 citing publications
Leading citing field
Neurodevelopmental Disorders
1,217 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v5n3, Jan. 2002-
v5n3, Jan. 2002-
Active Coverage
Research Focus & Classification
Indexed Subjects
Neurodevelopmental Disorders
Issuing & Sponsoring Bodies
Contributor
Multi-Health Systems Inc
Broad Categories
Psychiatry
Neurodevelopmental Disorders
MeSH Descriptors
Attention Deficit Disorder with Hyperactivity
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/10870547261492120
Open DOI
Extended-Release Guanfacine Hydrochloride is Safe and Effective as Mono- and Adjunctive Therapy in Children and Adolescents with ADHD: A Naturalistic, Multi-Center, Patient-Reported Outcome Measures–Based Study
Aims: Attention-deficit hyperactivity disorder (ADHD) is characterized by impairing and age-inappropriate inattention, hyperactivity, and impulsivity. Extended-release guanfacine hydrochloride (GXR) is a selective α2A-adrenergic agonist ...
02
DOI 10.1177/10870547261493758
Open DOI
The Effect of Stimulant Medications on Symptom and Treatment Outcomes in Adults With Comorbid Attention-Deficit/Hyperactivity and Substance Use Disorder: A Systematic Review and Meta-Analysis
Objective: Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) are increasingly recognized among adults and frequently co-occur with substance use disorders (SUD). Changing guidelines and complexity of treatment merit a review of...
03
DOI 10.1177/10870547261489132
Open DOI
Integrating Behavioral Sleep Medicine with Behavioral Parent Training for Preschool ADHD: Stakeholder Insights for an Early Childhood Intervention
Objectives: Behavioral Parenting Training (BPT), the gold-standard treatment for preschool attention-deficit/hyperactivity disorder (ADHD), does not consistently improve core symptoms of inattention and hyperactivity/impulsivity. Pairing...
04
DOI 10.1177/10870547261483444
Open DOI
Clinically Meaningful Within-Patient Change in Core Attention-Deficit/Hyperactivity Disorder Symptoms in Children and Adolescents Treated With Centanafadine: Results From Two Phase 3 Randomized Clinical Trials
Background: Attention-deficit/hyperactivity disorder (ADHD) is characterized by core symptoms of inattention, hyperactivity, and impulsivity that are persistent and can interfere with daily functioning. Centanafadine is a norepinephrine,...
05
DOI 10.1177/10870547261487760
Open DOI
Parsing the Longitudinal Relationship Between Avoidant Automatic Thoughts and Avoidance
Purpose: Avoidant automatic thoughts (AAT) have been proposed as a mechanism of problematic avoidance in ADHD. AAT are positively associated with task avoidance in the moment; however, the longitudinal and directional nature of this rela...
06
DOI 10.1177/10870547261469626
Open DOI
The Association Between Attention-Deficit Hyperactivity Disorder and Gastrointestinal Symptoms: A Systematic Review and Meta-Analysis
Introduction: Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental condition with rising prevalence worldwide. Although alterations in the gut–brain axis have been implicated in its pathophysiology, underlying mechanis...
07
DOI 10.1177/10870547261483459
Open DOI
Therapist-guided Internet-delivered versus Face-to-face CBT for Adults with ADHD: Differential Long-Term Maintenance and Exploratory Correlational Pathways
Objective: Therapist-guided Internet-delivered Cognitive Behavioral Therapy (iCBT) offers a promising alternative to face-to-face CBT (FTF-CBT) for adults with attention-deficit/hyperactivity disorder (ADHD), but evidence on its comparat...
08
DOI 10.1177/10870547261483457
Open DOI
Electroencephalographic Signatures of Methylphenidate in ADHD: A Systematic Review and 10 Recommendations for Future Research
Objective: Methylphenidate is the first-line treatment for ADHD, yet its neurocognitive mechanisms remain incompletely understood. Electroencephalography (EEG) has been used to examine methylphenidate’s effects on brain function and has ...
09
DOI 10.1177/10870547261478344
Open DOI
Comprehensive Treatment and Monthly 2 Year Follow-Up in Children With ADHD: Randomized Controlled Prospective Study
Objectives: To evaluate the efficacy of regular monthly follow up in maintaining treatment gains versus follow up as needed in the community for children ages 6 to 12 years with ADHD. Methods: One hundred and eighty six children, age 6 t...
10
DOI 10.1177/10870547261484217
Open DOI
Parsing Day-to-Day Dynamics of ADHD and Perceived Stress in College Students: An Ecological Momentary Assessment Study
Objective: Although ADHD is characterized as a lifelong condition, emerging evidence indicates that symptom severity can fluctuate day-to-day. In this study, we examined whether these fluctuations are directionally associated with fluctu...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
v.4, no. 4 (Apr. 2001)20020429 Notice not published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper